Lakefront Biotherapeutics NV annual total assets
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Lakefront Biotherapeutics NV Total Assets Growth & History (LKFT)
Lakefront Biotherapeutics NV's total assets was €3.41B for fiscal 2025.
View full Lakefront Biotherapeutics NV company overviewLakefront Biotherapeutics NV annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €3.41B | −€729.2M | −17.63% |
| 2024 | 2024-12-31 | €4.14B | −€221.7M | −5.09% |
| 2023 | 2023-12-31 | €4.36B | −€377.0M | −7.96% |
| 2022 | 2022-12-31 | €4.73B | −€458.8M | −8.83% |
| 2021 | 2021-12-31 | €5.19B | −€524.6M | −9.17% |
| 2020 | 2020-12-31 | €5.72B | −€350.9M | −5.78% |
| 2019 | 2019-12-31 | €6.07B | €4.63B | +321.58% |
| 2018 | 2018-12-31 | €1.44B | €153.2M | +11.91% |
| 2017 | 2017-12-31 | €1.29B | €202.9M | +18.73% |
| 2016 | 2016-12-31 | €1.08B | €640.8M | +144.81% |
| 2015 | 2015-12-31 | €442.5M | — | — |
Lakefront Biotherapeutics NV quarterly total assets
Q2.18
Q4.18
Q2.19
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | €3.35B | −€467.0M | −12.23% |
| Q1 2026 | 2026-03-31 | €3.37B | −€649.5M | −16.15% |
| Q4 2025 | 2025-12-31 | €3.41B | −€729.2M | −17.63% |
| Q3 2025 | 2025-09-30 | €3.51B | — | — |
| Q2 2025 | 2025-06-30 | €3.82B | — | — |
| Q1 2025 | 2025-03-31 | €4.02B | — | — |
| Q4 2024 | 2024-12-31 | €4.14B | −€221.7M | −5.09% |
| Q4 2023 | 2023-12-31 | €4.36B | −€377.0M | −7.96% |
| Q4 2022 | 2022-12-31 | €4.73B | −€458.8M | −8.83% |
| Q4 2021 | 2021-12-31 | €5.19B | −€524.6M | −9.17% |
| Q2 2021 | 2021-06-30 | €5.43B | −€420.9M | −7.19% |
| Q4 2020 | 2020-12-31 | €5.72B | −€350.9M | −5.78% |
| Q2 2020 | 2020-06-30 | €5.85B | €4.49B | +330.94% |
| Q4 2019 | 2019-12-31 | €6.07B | €4.63B | +321.58% |
| Q2 2019 | 2019-06-30 | €1.36B | €153.5M | +12.75% |
| Q4 2018 | 2018-12-31 | €1.44B | — | — |
| Q2 2018 | 2018-06-30 | €1.20B | — | — |
Lakefront Biotherapeutics NV total assets trends
Over the last five fiscal years, Lakefront Biotherapeutics NV's total assets decreased from €5.72B to €3.41B, a change of −€2.31B. The latest reported quarter, Q2 2026, shows €3.35B.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakefront Biotherapeutics NV source filings ↗